Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 20, 2023

SELL
$80.03 - $92.81 $1,840 - $2,134
-23 Reduced 4.12%
535 $49,000
Q2 2022

Aug 03, 2022

SELL
$80.52 - $93.75 $2,013 - $2,343
-25 Reduced 4.29%
558 $47,000
Q1 2022

Apr 29, 2022

BUY
$80.11 - $90.62 $160 - $181
2 Added 0.34%
583 $51,000
Q4 2021

Jan 18, 2022

BUY
$79.7 - $88.13 $1,833 - $2,026
23 Added 4.12%
581 $51,000
Q3 2021

Nov 04, 2021

SELL
$81.78 - $95.14 $1,880 - $2,188
-23 Reduced 3.96%
558 $46,000
Q2 2021

Aug 03, 2021

SELL
$85.24 - $94.15 $1,022 - $1,129
-12 Reduced 2.02%
581 $53,000
Q1 2021

May 10, 2021

SELL
$83.5 - $98.47 $7,431 - $8,763
-89 Reduced 13.05%
593 $51,000
Q4 2020

Jan 27, 2021

BUY
$78.07 - $94.43 $53,243 - $64,401
682 New
682 $64,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Accel Wealth Management Portfolio

Follow Accel Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accel Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Accel Wealth Management with notifications on news.